Literature DB >> 8218954

HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies.

J F Zagury1, J Bernard, A Achour, A Astgen, A Lachgar, L Fall, C Carelli, W Issing, J P Mbika, H Cantalloube.   

Abstract

We have previously unravelled the striking SLWDQ pentapeptide identity between HIV-1 env gp120 and the CD4 molecule. We show here that this pentapeptide is required for the functioning of the co-stimulatory MHC-CD4 signal in T4-cell activation since it suppresses antigen-induced T-cell proliferation. Moreover, concerning the MHC class II counterpart, the LNGQEETGVVSTN sequence which strongly inhibits T-cell immune activation is likely to be part of the functional site of the molecule. Interestingly the MHC/gp120 homology described by Young overlaps this MHC region. We further report that the gp120 SLWDQ peptide triggers an immune reaction which is both humoral (anti-SLWDQ antibodies) and cellular (CTLs against autologous targets carrying the pentapeptide) in HIV-1 infected individuals. Finally, anti-SLWDQ antibodies from patients sera purified by column chromatography strongly inhibit antigen-induced immune T-cell activation. This result led us to postulate that these antibodies found in high titers in HIV-1 infected individuals could contribute to set up the progressive systemic immune T-cell suppression characterizing AIDS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218954     DOI: 10.1016/0753-3322(93)90297-x

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  1 in total

1.  Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients.

Authors:  A Amara; C Chaugier; J M Ragnaud; M Geffard
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.